Skip to main content
Skip to footer
Home
Home
About
Overview
Management Team
Board of Directors
Medical & Scientific Advisors
Alzheimer’s
Overview
AD Clinics
Markets
Resources
Pipeline
Overview
NP-251 (Repirinast)
AP-188 (DMT)
Companies
Algernon NeuroScience
News & Media
News Releases
IR Calendar
Presentations
Videos/Articles
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEDAR
Governance
Contact
News Releases
Investors
Investors
Overview
News & Events
Overview
News Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Annual General Meeting
Analysts
Stock Data
CSE:AGN
OTCQB:AGNPF
XFRA:AGW0
SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Year
All Years
2025
2024
2023
2022
2021
2020
2019
Category
All Releases
Financial Releases
Feb 19, 2019 7:00am EST
Algernon Pharmaceuticals Begins Trading on The CSE Under The Symbol AGN
Previous Page
arrow_back
Page
1
…
…
Page
14
Page
15
Page
16
Page
17
Page
18
Page
19
Page
20
Page
21
Page
22
Page
23
rss_feed
News RSS
Facebook
Twitter
LinkedIn
Email Alerts
Email Alerts
Contacts
RSS News Feed
